Want to see IL:NRGN full AI Analyst Report?
Total Valuation
Nrgene has a market cap or net worth of ₪28.52M. The enterprise value is 5.76M.
Market Cap₪28.52M
Enterprise Value5.76M
Share Statistics
Nrgene has 13,327,785 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding13,327,785
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nrgene’s return on equity (ROE) is -0.35 and return on invested capital (ROIC) is -33.12%.
Return on Equity (ROE)-0.35
Return on Assets (ROA)-0.16
Return on Invested Capital (ROIC)-33.12%
Return on Capital Employed (ROCE)-0.35
Revenue Per Employee109.31K
Profits Per Employee-53.79K
Employee Count29
Asset Turnover0.33
Inventory Turnover19.53
Valuation Ratios
The current PE Ratio of Nrgene is ―. Nrgene’s PEG ratio is 0.09.
PE Ratio―
PS Ratio2.64
PB Ratio1.94
Price to Fair Value1.94
Price to FCF116.02
Price to Operating Cash Flow10.35
PEG Ratio0.09
Income Statement
In the last 12 months, Nrgene had revenue of 3.17M and earned -1.50M in profits. Earnings per share was -0.13.
Revenue3.17M
Gross Profit1.92M
Operating Income-1.57M
Pretax Income-1.52M
Net Income-1.50M
EBITDA-965.00K
Earnings Per Share (EPS)-0.13
Cash Flow
In the last 12 months, operating cash flow was 855.00K and capital expenditures -783.00K, giving a free cash flow of 72.00K billion.
Operating Cash Flow855.00K
Free Cash Flow72.00K
Free Cash Flow per Share<0.01
Dividends & Yields
Nrgene pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change-18.07%
50-Day Moving Average228.32
200-Day Moving Average―
Relative Strength Index (RSI)71.57
Average Volume (3m)27.56K
Important Dates
Nrgene upcoming earnings date is Mar 31, 2026, TBA (Not Confirmed).
Last Earnings DateSep 2, 2025
Next Earnings DateMar 31, 2026
Ex-Dividend Date―
Financial Position
Nrgene as a current ratio of 1.23, with Debt / Equity ratio of 4.20%
Current Ratio1.23
Quick Ratio1.22
Debt to Market Cap0.02
Net Debt to EBITDA4.10
Interest Coverage Ratio-47.58
Taxes
In the past 12 months, Nrgene has paid 35.00K in taxes.
Income Tax35.00K
Effective Tax Rate-0.02
Enterprise Valuation
Nrgene EV to EBITDA ratio is -4.55, with an EV/FCF ratio of 61.05.
EV to Sales1.39
EV to EBITDA-4.55
EV to Free Cash Flow61.05
EV to Operating Cash Flow5.14
Balance Sheet
Nrgene has ₪5.30M in cash and marketable securities with ₪181.00K in debt, giving a net cash position of ₪5.12M billion.
Cash & Marketable Securities₪5.30M
Total Debt₪181.00K
Net Cash₪5.12M
Net Cash Per Share₪0.38
Tangible Book Value Per Share₪0.11
Margins
Gross margin is 60.57%, with operating margin of -49.53%, and net profit margin of -47.38%.
Gross Margin60.57%
Operating Margin-49.53%
Pretax Margin-48.11%
Net Profit Margin-47.38%
EBITDA Margin-30.44%
EBIT Margin-47.07%
Analyst Forecast
The average price target for Nrgene is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast123.42%
EPS Growth Forecast55.25%